Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fenofibrate (fenoglide) (1 trial)
laropiprant (1 trial)
niacin (1 trial)
Diabetes Mellitus, Type 2 (Phase 4)
Dyslipidemias (Phase 4)
Trials (1 total)
Trial APIs (3 total)